A Study of Nivolumab Combined With Cabozantinib Compared to Sunitinib in Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Bristol-Myers Squibb
Related studies linked through entity extraction aliases.
A Study Comparing Nivolumab, Nivolumab in Combination With Ipilimumab and Placebo in Participants With Localized Kidney Cancer Who Underwent Surgery to Remove Part of a Kidney
- Status
- COMPLETED
- Phase
- PHASE3
A Study of Nivolumab Plus Brentuximab Vedotin Versus Brentuximab Vedotin Alone in Patients With Advanced Stage Classical Hodgkin Lymphoma, Who Are Relapsed/ Refractory or Who Are Not Eligible for Autologous Stem Cell Transplant,
- Status
- TERMINATED
- Phase
- PHASE3
Phase 1/2 Study of Tivozanib in Combination With Nivolumab in Subjects With RCC
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Effects of Concomitant Administration of BMS-986195 on Methotrexate, Caffeine, Montelukast, Flurbiprofen, Omeprazole, Midazolam, Digoxin, and Pravastatin
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate the Safety and Efficacy of Nivolumab Monotherapy and Nivolumab in Combination With Ipilimumab in Pediatric Participants With High Grade Primary Central Nervous System (CNS) Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Expanded Access to Nivolumab (Opdivo)
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Expanded Access to Elotuzumab (Empliciti) for Multiple Myeloma
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
CD40 Agonistic Antibody APX005M (Sotigalimab) in Combination With Nivolumab
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study to Evaluate Adaptive Dosing of Ipilimumab and Nivolumab Combination Immunotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Nivolumab in Treating Patients With Advanced Metastatic Non-small Cell Lung Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
Study of Front Line Therapy With Nivolumab and Salvage Nivolumab + Ipilimumab in Patients With Advanced Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of ONO-4538 in Non-Squamous Non-Small Cell Lung Cancer (TASUKI-52)
- Status
- COMPLETED
- Phase
- PHASE3
Observational Study of Nivolumab in Participants in Germany With Squamous Cell Carcinoma of the Head and Neck (SCCHN) Progressing on or After Platinum-Based Therapy
- Status
- COMPLETED
- Phase
- N/A
First-In-Human Study of Monoclonal Antibody BMS-986218 by Itself and in Combination With Nivolumab in Participants With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Trial of Anti-PD-1 (Nivolumab) in Bladder Cancer Patients Recently Treated With Intravesical BCG Immunotherapy
- Status
- TERMINATED
- Phase
- PHASE1
Nivolumab and Ipilimumab and Radiation Therapy in MSS and MSI High Colorectal and Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Test the Safety and Effectiveness of Nivolumab Combined With Daratumumab in Patients With Pancreatic, Non-Small Cell Lung or Triple Negative Breast Cancers, That Have Advanced or Have Spread
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety Study of Nivolumab to Treat Advanced or Metastatic Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical and Economic Outcomes of Oral Anticoagulants in Non-valvular Atrial Fibrillation
- Status
- COMPLETED
- Phase
- N/A